At a glance
ClinicalIndex Comparison RecordN/ACompleted· 88 enrolled
Drug / intervention
Flow cytometryother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Regulatory T Cells and Their Cytokines Profile in Different Groups of Hepatitis c Infected Patients: A Case Control Study
In Brief
An observational study evaluating Flow cytometry for Hepatitis C. Completed, enrolled 88 participants across 1 site.
Detailed Summary
Chronic hepatitis C infection is a global worldwide health problem with an increasing burden year-by-year, particularly in areas with a high endemicity like Egypt . The World Health Organization estimates that approximately 200 million people worldwide are infected with hepatitis c virus. In Egypt, it was estimated that 15 % of Egyptians have serologic evidence of hepatitis C viral infection .
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsHepatitis C
CountriesEgypt
Collaborators--
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
First PostedJun 2017
Enrollment StartJul 2018
Primary CompletionAug 2019
TodayJul 2026
First PostedJun 14, 2017
Enrollment StartJul 1, 2018
Primary CompletionAug 1, 2019
TodayJul 2, 2026
Enrollment to primary: 1.1 yearsPosted 9.0 years ago
Interventions
Flow cytometryother
Isolation of T regulatory cells from blood